QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 greenwich-lifesciences-to-join-russell-2000-and-3000-indexes-in-july

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its P...

 greenwich-lifesciences-announces-private-placement-of-25m-at-1430-per-share-closing-expected-on-or-about-june-18-2024

The company announced that it has entered into a securities purchase agreement with its Chief Executive Officer, Snehal Patel, ...

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-maintains-36-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price t...

 insiders-buying-greenwich-lifesciences-and-2-other-stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-maintains-36-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price t...

 greenwich-lifesciences-flamingo-01-phase-3-trial-which-is-evaluating-glsi-100-an-immunotherapy-to-prevent-breast-cancer-recurrences-approved-to-expand-into-five-largest-european-countries

The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, an...

 greenwich-lifesciences-flamingo-01-manufacturing--protocol-accepted-by-european-regulators

The Company was informed that the manufacturing, non-clinical, clinical, statistical, and regulatory sections of its applicatio...

 hc-wainwright--co-maintains-buy-on-greenwich-lifesciences-lowers-price-target-to-36

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targe...

 why-greenwich-lifesciences-glsi-stock-is-skyrocketing

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III ...

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 369 companies set new 52-week lows.

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-lowers-price-target-to-38

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targ...

 47m-bet-on-tillys-check-out-these-3-stocks-insiders-are-buying

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

 why-coupa-software-shares-jumped-around-29-here-are-72-biggest-movers-from-wednesday

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesda...

 bitcoin-holder-microstrategy-and-4-more-short-squeeze-stocks-that-could-soar-this-week

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.